Benitec Biopharma CEO Jerel Banks' 2024 pay jumps 205% to $2.8M
Benitec Biopharma reports 2024 executive compensation
By ExecPay News
Published: October 23, 2024
Benitec Biopharma reported fiscal year 2024 executive compensation information on October 23, 2024.
In 2024, two executives at Benitec Biopharma received on average a compensation package of $2M, a 194% increase compared to previous year.
Average pay of disclosed executives at Benitec Biopharma
Jerel A. Banks, Chief Executive Officer, received $2.8M in total, which increased by 205% compared to 2023. 76% of Banks' compensation, or $2.1M, was in option awards. Banks also received $628K in salary and $38K in other compensation.
Megan Boston, Executive Director, received a compensation package of $1.3M, which increased by 172% compared to previous year. 72% of the compensation package, or $914K, was in option awards.
Related executives
You may also like
Source: SEC filing on October 23, 2024.